Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe (PERISCOPE)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment.
| Condition |
|---|
|
Complication of Surgical Procedure Acute Respiratory Failure, Adult Postoperative Respiratory Complications Pulmonary Failure Surgical Complications From General Anesthesia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe: Predicting Postoperative Pulmonary Complications in Europe: a 7-day Data Collection, Prospective, Observational Study |
- The main outcome, defined as a postoperative pulmonary complications (PPC), will be a composite of the in-hospital fatal or non-fatal postoperative events. [ Time Frame: 3 days to 5 weeks ] [ Designated as safety issue: No ]Will include:Mild respiratory failure;Severe respiratory failure;acute lung injury(ALI)/Acute respiratory distress syndrome(ARDS);Suspected pulmonary infection;Pulmonary infiltrate;Pleural effusion;Atelectasis;Pneumothorax;Bronchospasm;Aspiration Pneumonitis;Cardiopulmonary edema.Investigators will not modify centre usual patient management. Patients with PPCs will identify by consulting medical records and looking for events fulfilling PPCdefinition. Diagnosis date for every complication will be recorded.Participants will be followed during in-hospital stay expected average maximum 5 weeks.
- a) Postoperative length of stay [ Time Frame: 3 days to 5 weeks ] [ Designated as safety issue: No ]Participants will be followed for the duration of in-hospital stay, an expected average of maximum 5 weeks.
- b) In-hospital mortality [ Time Frame: up to 5 weeks ] [ Designated as safety issue: No ]Participants will be followed for the duration of in-hospital stay, an expected average of maximum 5 weeks.
| Enrollment: | 5183 |
| Study Start Date: | May 2011 |
| Study Completion Date: | September 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
In-patient Adult Non-obstetricSurgical
Consecutive patients admitted to participating centres undergoing surgery Non-obstetric in-hospital surgical procedure, elective or emergent, under general anaesthesia (alone or in combination with regional/neuraxial anaesthesia), neuraxial anaesthesia or plexus block (with and without sedation). All eligible patients undergoing surgery within the seven day study period will be recruited wherever possible. |
Detailed Description:
Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric in-hospital surgical procedure under general or regional anaesthesia during a continued 7-day period of recruitment.
Participating centres throughout Europe will contribute routine clinical data describing all eligible patients who undergo surgery during a continuous week (7-days) at convenience of every department within a period of two months from May 1st to July 1st 2011. A questionnaire of around 50 items will be filled during the pre, intra and postoperative periods. The follow-up will end at discharge. The aim of the PERISCOPE study is to validate a simple score to predict postoperative pulmonary complications(PPCs). This score has recently been published in Anesthesiology and you can access linking to: http://journals.lww.com/anesthesiology/Fulltext/2010/12000/Prediction_of_Postoperative_Pulmonary.20.aspx
TIMEFRAME Participants will be followed for the duration of in-hospital stay, an expected average of maximum 5 weeks.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
In-patient adult non-obstetric surgery
Inclusion Criteria:
Patients undergoing a non-obstetric in-hospital surgical procedure, elective or emergent, under general anaesthesia (alone or in combination with regional/neuraxial anaesthesia), neuraxial anaesthesia or plexus block (with and without sedation).
Exclusion Criteria:
- age <18 years
- obstetric procedures or any procedure during pregnancy
- regional anaesthesia alone, except to neuroaxial and plexus anaesthesia
- procedures outside the operating room
- procedures related to a previous postoperative complication
- transplantation
- patients with preoperatively intubated trachea
- outpatient procedures, defined as those requiring less than one day's stay for a patient alive at discharge.
Contacts and Locations
Show 63 Study Locations| Study Director: | Jaume Canet, MD | Hospital Universitari Germans Trias I Pujol, Barcelona, Spain |
| Principal Investigator: | Sergi Sabaté, MD, PhD | Fundació Puigvert (IUNA), Barcelona, Spain |
| Principal Investigator: | Olivier Langeron, MD, PhD | Hôpital de la Pitié-Salpêtrière, Paris, France |
| Principal Investigator: | Marcelo Gama de Abreu, MD,PhD,DEAA | University Hospital Carl Gustav Carus Dresden University of Technology, Dresden, Germany |
| Principal Investigator: | Lluís Gallart, MD | Parc de Salut Mar Anaesthesiology Research Group IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain |
| Principal Investigator: | Francisco Javier Belda, MD | Hospital Clínico Universitario de Valencia, Valencia, Spain |
| Principal Investigator: | Paolo Pelosi, MD, PhD | University of Genoa, Genoa, Italy - San Martino Hospital, Genoa, Italy |
| Study Chair: | Valentin Mazo, MD | Hospital Universitari Germans Trias I Pujol, Barcelona, Spain |
| Principal Investigator: | Andreas Hoeft, MD | University Hospital of Bonn Medical School |
More Information
Additional Information:
Publications:
| Responsible Party: | European Society of Anaesthesiology |
| ClinicalTrials.gov Identifier: | NCT01346709 History of Changes |
| Other Study ID Numbers: | PERISCOPE |
| Study First Received: | April 20, 2011 |
| Last Updated: | February 12, 2013 |
| Health Authority: | Albania: Ministry of Health Department of Pharmacy Belgium: Ethics Committee Bosnia: Federal Ministry of Health Croatia: Ethics Committee Czech Republic: Ethics Committee Estonia: Research Ethics Committee Estonia: The State Agency of Medicine France: Institutional Ethical Committee Germany: Ethics Commission Hungary: Institutional Ethics Committee Italy: Ethics Committee Latvia: Institutional Review Board Lithuania: Bioethics Committee Luxembourg: Comite National d'Ethique de Recherche Poland: Ethics Committee Portugal: Ethics Committee for Clinical Research Romania: Ethics Committee Russia: Ethics Committee Spain: Comité Ético de Investigación Clínica Turkey: Ethics Committee |
Keywords provided by European Society of Anaesthesiology:
|
Operative surgical procedures Postoperative pulmonary complications (PPC) Epidemiological Study ARISCAT score Risk Score Europe PERISCOPE observational study Mild respiratory failure Severe respiratory failure acute lung injury (ALI) Acute respiratory distress syndrome (ARDS) |
Suspected pulmonary infection Pulmonary infiltrate Pleural effusion Atelectasis Pneumothorax Bronchospasm Aspiration Pneumonitis Cardiopulmonary edema Prospective Evaluation nonobstetric in-hospital surgical procedure general or regional anaesthesia continued 7-day period recruitment |
Additional relevant MeSH terms:
|
Respiratory Distress Syndrome, Adult Respiratory Insufficiency Lung Diseases Respiratory Tract Diseases Respiration Disorders |
ClinicalTrials.gov processed this record on May 19, 2013